|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2282758 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09738534.8 |
| Date of filing the European patent application | 2009-04-28 | |
| (97) | Date of publication of the European application | 2011-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-21 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (86) | Number | PCT/IB2009/051731 |
| Date | 2009-04-28 |
| (87) | Number | WO 2009/133521 |
| Date | 2009-11-05 |
| (30) | Number | Date | Country code |
| 48865 P | 2008-04-29 | US |
| (72) |
LANNFELT, Lars, SE
BERGSTRÖM, Joakim, SE
INGELSSON, Martin, SE
GELLERFORS, Pär, SE
|
| (73) |
BioArctic AB,
Warfvinges väg 35, 112 51 Stockholm,
SE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai ir vakcinos, skirti su alfa sinukleinu susijusių sutrikimų gydymo ir diagnostiniams metodams |
| ANTIBODIES AND VACCINES FOR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALPHA-SYNUCLEIN-RELATED DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2024-03-27 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-06-27 |